RecruitingNCT06210698

Angioedema Biomarker Research Study

Sponsor

Foundation For Rare Disease Research

Enrollment

600 participants

Start Date

Jan 15, 2024

Study Type

OBSERVATIONAL

Conditions

Urticaria Mastocytosis Angioedema Indolent Systemic Mastocytosis C1 Inhibitor Deficiency Angioedemas, Hereditary ACE Inhibitor-Induced Angioedema Systemic Mastocytoses

Summary

This clinical trial aims to evaluate and compare novel and commercially available diagnostic assays through blood tests for the differential diagnosis and comprehensive assessment of patients experiencing recurrent angioedema attacks, including both urticarial and non-urticarial angioedema. The primary objective is to assess the efficiency of novel diagnostic assays, both individually and in combination, in comparison to currently available commercial tests. The ultimate goal is to establish the feasibility of developing an affordable and accurate laboratory test capable of diagnosing the diverse etiological manifestations of angioedema.

Eligibility

Min Age: 12 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Venipuncture for people with ace inhibitor-induced angioedema, angioedema, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 12 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.